Physician profile
Gregory Tanner
NPI 1467737759
$12,753.72
in general payments reported to CMS, 2019-2025
21 companies · $1,715 in 2025
The $1,715 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $560 · 2020: $1,851 · 2021: $1,499 · 2022: $2,627 · 2023: $753 · 2024: $3,749 · 2025: $1,715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,559 · Travel and Lodging: $2,244 · Consulting Fee: $1,403 · Education: $10.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,559.12 |
| Travel and Lodging | $2,243.75 |
| Consulting Fee | $1,403.04 |
| Education | $10.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,805.21 | 2023-2025 | Journey II, Legion Revision, Journey |
| Stryker Corporation | $2,453.71 | 2019-2024 | Mako, Aequalis Perform |
| Depuy Synthes Products, INC. | $1,871.00 | 2024-2025 | Velys |
| Zimmer Biomet Holdings, INC. | $1,232.58 | 2021-2025 | Rosa, Comprehensive, Affixus |
| Depuy Synthes Sales INC. | $1,218.35 | 2019-2025 | Velys, Attune |
| Fortis Surgical, LLC | $1,043.00 | 2020 | |
| Medical Device Business Services, INC. | $955.39 | 2020-2023 | Inhance |
| Pacira Pharmaceuticals Incorporated | $463.24 | 2022-2025 | Iovera, Exparel, Zilretta |
| Pacira Therapeutics, INC. | $208.65 | 2019-2021 | |
| Fidia Pharma USA INC. | $140.75 | 2019-2020 | |
| Innovation Technologies INC | $134.98 | 2024 | Irrisept |
| Avanos Medical | $51.69 | 2019-2021 | |
| Ermi LLC | $38.68 | 2020 | |
| Bioventus LLC | $30.03 | 2021 | |
| Abbott Laboratories | $19.70 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Theragen, INC. | $17.32 | 2020 | |
| Horizon Therapeutics Plc | $15.92 | 2021 | |
| Trevena, INC. | $15.46 | 2021 | |
| Pfizer INC. | $13.56 | 2019 | |
| Medtronic USA, INC. | $12.88 | 2019 | |
| Integra Lifesciences Corporation | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Tanner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.